• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Organisation › Details

Bayer CropScience AG

About Bayer CropScience: Bayer is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer CropScience, the subgroup of Bayer AG responsible for the agricultural business, has annual sales of EUR 8,819 million (2013) and is one of the world’s leading innovative crop science companies in the areas of seeds, crop protection and non-agricultural pest control. The company offers an outstanding range of products including high value seeds, innovative crop protection solutions based on chemical and biological modes of action as well as an extensive service backup for modern, sustainable agriculture. In the area of non-agricultural applications, Bayer CropScience has a broad portfolio of products and services to control pests from home and garden to forestry applications. The company has a global workforce of 22,400 and is represented in more than 120 countries. *

 

	Start	2002-10-01 renamed
	Group	Bayer (Group)
	Industry	AGRI LIFE SCIENCES
	Person	Peterson, Sandra E. (JnJ 201212– before Bayer 201010–201211 CEO of Bayer CropScience before Bayer HealthCare)
	Region	Monheim
	Country	Germany
	Street	50 Alfred-Nobel-Str.
	City	40789 Monheim
	Tel	+49-2173-38-0
		Address record changed: 2020-12-02
Basic data	Employees	H: 10,001 to 50,00 (2013-12-31)
	Currency	EUR
	Annual sales	8,819,000,000 (sales, annual (2013) 2013-12-31)
		* Document for �About Section�: Bayer AG. (10/29/14). "Press Release: Bayer CropScience Acquires Certain DuPont Crop Protection Land Management Business Assets". Monheim & Wilmington, DE.
		Record changed: 2020-08-28

Advertisement

More documents for Bayer (Group)

• [1] CureVac N.V.. (1/7/21). "Press Release: CureVac and Bayer Join Forces on COVID-19 Vaccine Candidate CVnCoV". Berlin, Tübingen & Boston; MA....
• [2] Bayer AG. (1/6/21). "Press Release: Leaps by Bayer Leads USD 105 Million Series B Financing in Senti Bio to Develop Next-generation Cell and Gene Therapies Using Advanced Gene Circuit Technology Platform". Leverkusen & South San Francisco, CA....
• [3] Veracyte, Inc.. (12/22/20). "Press Release: Bayer and Veracyte Announce Precision Oncology Collaboration in Thyroid Cancer". Whippany, NJ & San Francisco, CA....
• [4] NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh....
• [5] Bayer AG. (12/6/20). "Press Release: Bayer and Atara Biotherapeutics Enter Strategic Collaboration for Mesothelin-Targeted CAR T-cell Therapies for Solid Tumors". Whippany, NJ & South San Francisco, CA....
• [6] Semalytix GmbH. (11/24/20). "Press Release: Corporate Vice President of Bayer Pharmaceuticals Becomes Advisor to Semalytix". Bielefeld....
• [7] Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen....
• [8] Bayer AG. (11/9/20). "Press Release: Bayer Submits Marketing Authorization Applications for Finerenone in the U.S. and the EU for Patients with Chronic Kidney Disease and Type 2 Diabetes". Berlin....
• [9] Bayer AG. (10/27/20). "Press Release: Bayer Appoints Dr. Christian Rommel as New Head of Pharmaceuticals Research and Development". Berlin....
• [10] Bayer AG. (10/26/20). "Press Release: Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene Therapy". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Data Privacy  |  » Contact  |  The use of this website requires to accept the » Disclaimer!   |  A project of [iito] Business Intelligence © 2002-2021. Made in Germany.